ArticleAnatolian journal of cardiology2018
Fulminant myocarditis: Characteristics, treatment, and outcomes.
Article in Anatolian journal of cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
59 citing papers in PubMed, 2 syntheses or guidelines pooled it, 104 citations in OpenAlex.
- Brazilian Society of Cardiology Guideline on Myocarditis - 2022.Arquivos brasileiros de cardiologia · 2022Guideline
- Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis.Medicine · 2019Pooled it
- A 35-Year-Old Woman Presenting With Life-Threatening Fulminant Myocarditis After COVID-19: A Case Report.The American journal of case reports · 2026Article
- Clinical Characteristics and Outcomes of Cardiogenic Shock in Acute Myocarditis Versus Takotsubo Cardiomyopathy: A Propensity Matched Nationwide Analysis.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Article
- Article
- Characteristics and Outcomes of Multisystemic Inflammation in Patients Clinically Diagnosed With Non-COVID-19-Related Fulminant Myocarditis.Circulation reports · 2026Article
- Relation Between Neutrophil Count and Left Ventricular Ejection Fraction Following Acute Myocarditis in Adolescents: A Preliminary Study.Children (Basel, Switzerland) · 2025Article
- Fulminant Myocarditis with VA-ECMO Support: Clinical Characteristics and Prognosis in a Cohort from a Tertiary Transplant Center.Biomedicines · 2025Article
- Pan-immune-inflammation value: a new predictor of cardiac scar in hospitalized myocarditis patients.Biomarkers in medicine · 2025Article
- Fulminant Influenza Myocarditis Requiring Extracorporeal Membrane Oxygenation (ECMO) Support.Cureus · 2025Article
- Diagnosis and management of patients with fulminant myocarditis.European heart journal supplements : journal of the European Society of Cardiology · 2025Article
- The Role of tRNA-Derived Small RNAs (tsRNAs) in Regulating Cell Death of Cardiovascular Diseases.Biology · 2025Review
- Early clinical predictors of fulminant myocarditis in pediatric patients: a retrospective cohort study.Frontiers in cardiovascular medicine · 2025Article
- A case report of severe myocarditis combined with erythema multiforme caused by herpes simplex virus-1.Frontiers in cardiovascular medicine · 2025Article
- Diagnostic efficacy of soluble ST2 in pediatric fulminant myocarditis.Frontiers in pediatrics · 2025Article
- Comparison of predictors of survival among fulminant myocarditis patients undergoing veno-arterial extracorporeal membrane oxygenation in the adult and pediatric populations.Annals of medicine and surgery (2012) · 2024Article
- Outbreak of Acute Fulminant Myocarditis in Children in Campania Region, Italy: A Case Series.Children (Basel, Switzerland) · 2024Article
- Myocarditis - A silent killer in athletes: Comparative analysis on the evidence before and after COVID-19 pandemic.Sports medicine and health science · 2024Review
- Giant cell myocarditis with prolonged cardiac standstill after drug-induced hypersensitivity syndrome: a case report.ESC heart failure · 2024Article
- Changes in Cardiac Function Following Fulminant Myocarditis.Circulation. Heart failure · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myocarditis is an inflammatory disease of the myocardium with a broad spectrum of clinical presentations, ranging from mild symptoms to severe heart failure. The course of patients with myocarditis is heterogeneous, varying from partial or full clinical recovery in few days to advanced low cardiac output syndrome requiring mechanical circulatory support or heart transplantation. Fulminant myocarditis (FM) is a peculiar clinical condition and is an acute form of myocarditis, whose main characteristic is a rapidly progressive clinical course with the need for hemodynamic support. Despite the common medical belief of the past decades, recent comprehensive data, including a recent registry that compared FM with acute non-FM, highlighted that FM has a poor inhospital outcome, often requires advanced hemodynamic support, and may result in residual left ventricular dysfunction in survivors. This review aimed to provide an updated practical definition of FM, including essentials in the diagnosis and management of the disease. Finally, the outcome of FM was critically revised according to the current published registries focusing on the topic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.